Molecule
- Glimepiride (2 mg): A sulfonylurea that stimulates insulin secretion from pancreatic beta cells.
- Metformin PR (500mg): A biguanide that decreases hepatic glucose production and enhances insulin sensitivity.
Category
Anti-Diabetic Medication – 3rd gen SU+Biguanide.
Glimepiride 2 mg + Metformin Hydrochloride PR (500mg)
Glimihar-M2 is a combination oral antidiabetic medication containing Glimepiride (2 mg) and Metformin Hydrochloride PR (500mg) in a Prolonged-release formulation. It is designed to help individuals with Type 2 Diabetes Mellitus manage blood sugar levels effectively by stimulating insulin secretion and enhancing insulin sensitivity.
Benefits
- Enhanced Blood Sugar Control: Effectively regulates glucose levels in Type 2 Diabetes patients.
- Dual Action Formula: Stimulates insulin release and improves insulin utilization.
- Prolonged Release: Ensures prolonged therapeutic effect for better metabolic control.
Storage & Precautions
- Storage: Store in a cool, dry place below 30°C, protected from moisture and sunlight.
- Precautions: To be used under medical supervision. Not suitable for patients with severe kidney or liver impairment. Regular monitoring of blood glucose is recommended.
Packaging
Available in 10 x 10 tablets per box.